CONVATEC NORWAY AS

Operating

Et globalt selskap innen medisinske produkter og teknologier, med en ledende markedsposisjon innen stomipleie, sårbehandling, inkontinens, operasjon, kirurgi og intensiv pleie, og subcutane infusjonsprodukter.

Convatec produkter tilbyr en rekke kliniske og økonomiske fordeler, inkludert forebygging av infeksjon, beskyttelse av utsatt hud, forbedrede behandlingsresultater for pasienter og redusert total kostnad for pleien.

Selskapet skal drive produksjon og salg av helseomsorgsprodukter samt alt som naturlig står i forbindelse med dette, derunder investeringer og deltagelse i andre selskaper.

Produksjon, markedsføring og salg av helseomsorgsprodukter med særlig fokus på stomi-, intensiv/operasjon- og sårbehandlingsprodukter.

Keywords

pharmaceuticalshospital equipmentorthopedic articles

Organization

CEO: WS
Wenche Strøm-Magnussen1965
Chairman of the board: MC
Michael Christian Remy Jensen1967
Years since formation: 18 years; since Jun 12, 2008
Type: Limited company
VAT registered: Yes
Number of employees: 12

Ownership

Number of shares and share classes: 10,001; 1 share class
Total number of shareholders: 1; person

Financials

Total operating income 2024: 85,706,426; NOK
Annual total result 2024: 2,222,313; NOK
Total equity 2024: 34,192,507; NOK

Last update: Mar 13, 2026

Management

Management / administration

Name	Role	Shares
WS Wenche Strøm-Magnussen 1965	Managing Director/CEO	-

Board

Name	Role	Shares
MC Michael Christian Remy Jensen 1967	Chairman	-
ME Mark Edward Warren 1974	Board Member	-
WS Wenche Strøm-Magnussen 1965	Board Member	-

Others

Name	Role	Shares
C CEDRA NORGE AS	Auditor	-
K KPMG ACCOUNTING AS	Accountant	-
T TMF NORWAY AS	Accountant	-

Last update: Mar 18, 2026

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
IS International Services Gmb Convatec	Ordinary shares	10,001	100 %

Last update: Jun 2, 2025

Financials

in NOK

Summary

Year	2024	2023	2022	2021
Total operating income	85,706,426	84,059,767	100,529,914	85,151,460
Annual Total Result	2,222,313	1,566,499	3,005,561	1,866,895
Total assets	70,263,460	69,762,279	65,734,907	37,984,759
Total liabilities	36,070,952	44,526,807	44,066,281	24,888,849
Total equity	34,192,507	25,235,471	21,668,626	13,095,909

P&L

Year	2024	2023	2022	2021
Total operating income	85,706,426	84,059,767	100,529,914	85,151,460
Total operating costs	83,038,023	82,011,628	96,616,949	82,682,633
Operating result	2,668,403	2,048,139	3,912,965	2,468,827
Financial income/costs	282,421	69,253	44,357	3,858
Profit before tax	2,950,824	2,117,392	3,957,322	2,472,685
Total tax & extraordinary income/cost	728,511	550,893	951,761	605,790
Annual Total Result	2,222,313	1,566,499	3,005,561	1,866,895

Balance overview

Year	2024	2023	2022	2021
Total fixed assets	1,728,428	301,703	66,299	140,843
Total current assets	68,535,032	69,460,576	65,668,608	37,843,916
Total assets	70,263,460	69,762,279	65,734,907	37,984,759
Short term debt	36,070,952	44,526,807	44,066,281	24,888,849
Long term debt	0	0	0	0
Total liabilities	36,070,952	44,526,807	44,066,281	24,888,849
Contributed capital	7,383,852	7,383,852	21,668,626	13,095,909
Retained earnings	26,808,655	17,851,619	0	0
Total equity	34,192,507	25,235,471	21,668,626	13,095,909
Total equity and liabilities	70,263,459	69,762,278	65,734,907	37,984,758

Classification

21st company classification

BETA

Industrial large enterprise

CONVATEC NORWAY AS992 780 118